UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032085
Receipt number R000036603
Scientific Title A retrospective observational study investigating the change of transvalvular peak velocity among patients undergoing aortic valve replacement with bioprosthetic valve.
Date of disclosure of the study information 2018/05/01
Last modified on 2021/06/04 21:12:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective observational study investigating the change of transvalvular peak velocity among patients undergoing aortic valve replacement with bioprosthetic valve.

Acronym

AVR TEE study

Scientific Title

A retrospective observational study investigating the change of transvalvular peak velocity among patients undergoing aortic valve replacement with bioprosthetic valve.

Scientific Title:Acronym

AVR TEE study

Region

Japan


Condition

Condition

Patients undergoing aortic valve replacement with bioprosthetic valve.

Classification by specialty

Cardiology Surgery in general Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Aortic valve replacement (AVR) is an established procedure for treating aortic valvular diseases. Prosthesis-patient mismatch(PPM)is known as the factor increasing the postoperative mortality and morbidity. If intraoperative measurement of transvalvular peak velocity could predict postoperative PPM, intraoperative diagnosis and additional intervention may prevent postoperative PPM.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The interactions between time series variation of an adjusted peak trans-prosthetic valvular velocity and an intraoperative peak trans-prosthetic valvular velocity.

Key secondary outcomes

The interaction between time series variation of an adjusted peak trans-prosthetic valvular velocity and an implanted bio-prosthetic valve size, or a type of the implanted bio-prosthetic valve.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient undergoing aortic valve replacement with bioprosthetic valve.

Key exclusion criteria

none

Target sample size

700


Research contact person

Name of lead principal investigator

1st name Kimito
Middle name
Last name Minami

Organization

National Cerebral and Cardiovascular Center

Division name

Department of Surgical Intensive Care

Zip code

565-8565

Address

5-7-1 Fujishirodai, Suita, Osaka, Japan

TEL

06-6833-5012

Email

nann_5115@ybb.ne.jp


Public contact

Name of contact person

1st name Kimito
Middle name
Last name Minami

Organization

National Cerebral and Cardiovascular Center

Division name

Department of Surgical Intensive Care

Zip code

565-8565

Address

5-7-1 Fujishirodai, Suita, Osaka, Japan

TEL

06-6833-5012

Homepage URL


Email

nann_5115@ybb.ne.jp


Sponsor or person

Institute

National Cerebral and Cardiovascular Center

Institute

Department

Personal name



Funding Source

Organization

National Cerebral and Cardiovascular Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cerebral and Cardiovascular Center

Address

5-7-1 Fujishirodai, Suita, Osaka, Japan

Tel

06-6833-5012

Email

k.minami@ncvc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 01 Day


Related information

URL releasing protocol

https://www.jcvaonline.com/article/S1053-0770(19)30512-9/fulltext

Publication of results

Published


Result

URL related to results and publications

https://www.jcvaonline.com/article/S1053-0770(19)30512-9/fulltext

Number of participants that the trial has enrolled

556

Results

A multivariable logistic regression model was used to identify the predictors of patient-prosthesis mismatch at 1 year. There was no significant association between intraoperative peak velocity and peak velocity at 1 month (p = 0.419) or 1 year (p = 0.115). The implanted valve type (p < 0.001) and size (p < 0.001), but not intraoperative peak velocity (p = 0.503), were independent predictors of patient-prosthesis mismatch.

Results date posted

2019 Year 10 Month 04 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The study comprised 556 patients who underwent aortic valve replacement with a bioprosthetic valve.

Participant flow

Retrospectively reviewed from clinical record.

Adverse events

None.

Outcome measures

The associations between peak velocity values at the aforementioned 3 time points were analyzed using a multivariable nonlinear regression model. A multivariable logistic regression model was used to identify the predictors of patient-prosthesis mismatch at 1 year.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 04 Month 03 Day

Date of IRB

2018 Year 05 Month 28 Day

Anticipated trial start date

2018 Year 05 Month 28 Day

Last follow-up date

2018 Year 05 Month 28 Day

Date of closure to data entry

2018 Year 05 Month 28 Day

Date trial data considered complete

2018 Year 05 Month 28 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information

Intraoperative trans-prosthetic valvular peak velocity, postoperative trans-prosthetic valvular peak velocity were extracted from medical record. Trans-prosthetic valvular peak velocity were adjusted for age, sex, body surface area, size of implanted bio-prosthetic valve, type of implanted bio-prosthetic valve, presence or absence of aortic insufficiency, morphology of aortic valve (tricuspid or bicuspid valve), and preoperative stroke volume. The interaction between time-series variation of peak trans-prosthetic valvular velocity and intraoperative peak trans-prosthetic valvular velocity was assessed using a linear regression model adjusted by the Huber-White method for repeated measures data.


Management information

Registered date

2018 Year 04 Month 03 Day

Last modified on

2021 Year 06 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036603


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name